Latest Cetuximab Stories
ResearchMoz.us include new market research report "Monoclonal Antibodies Market in Colorectal Cancer to 2019" to its huge collection of research reports.
Patients with cancers driven by the protein KRAS, which are particularly hard to treat, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex.
Research institutes, regulators and the pharmaceutical industry are urged to cooperate to develop new approaches to testing cancer drugs, in order to bring the revolution in personalized medicine to patients across Europe.
Identifying the molecular profile of a tumor where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013), will hear on Monday.